Master Production Scheduling Factors Effecting Blood Collection Performance: Smart PLS-SEM Analysis
Journal of Research in Engineering and Computer Sciences · 2024
DOI: 10.63002/jrecs.25.679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Research in Engineering and Computer Sciences, 2024. Verfasst von Kaconco James und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
This study aimed to investigate relationship between master production scheduling factors and blood collection performance within a complex blood supply chain.
Methods
A self-administered questionnaire was employed to gather data from randomly selected blood bank participants. Smart PLS-SEM tool was used in the analysis.
Results
The findings indicated that master production scheduling factors have a considerable and positive influence on blood collection performance.
Conclusion
The improvement of blood collection performance is supported by master production scheduling. Consequently, it is advisable to prioritize blood collection site layout, repeat blood donor screening, and flexible transport means in order to achieve better blood collection performance.
Zitieren
APA
James, K., Betty, N., Thaddeo, M. J., Kirabira, J. B., & Otekat, G. (2024). Master Production Scheduling Factors Effecting Blood Collection Performance: Smart PLS-SEM Analysis. Journal of Research in Engineering and Computer Sciences. https://doi.org/10.63002/jrecs.25.679
Vancouver
James K, Betty N, Thaddeo MJ, Kirabira JB, Otekat G. Master Production Scheduling Factors Effecting Blood Collection Performance: Smart PLS-SEM Analysis. Journal of Research in Engineering and Computer Sciences. 2024. doi:10.63002/jrecs.25.679
BibTeX
@article{James2024,
author = {James, Kaconco and Betty, Nabuuma and Thaddeo, Mugarura Jude and Kirabira, John Baptist and Otekat, Grace},
title = {Master Production Scheduling Factors Effecting Blood Collection Performance: Smart PLS-SEM Analysis},
journal = {Journal of Research in Engineering and Computer Sciences},
year = {2024},
doi = {10.63002/jrecs.25.679}
}
EUVIMED